Understanding the Effects of Risankizumab on Health Over Time
Contact
Description
This study aims to evaluate how Risankizumab, a medication used to treat Crohn's Disease, works in children. It focuses on understanding how factors such as age, weight, and the way the drug is processed in the body may influence its effectiveness and safety in pediatric patients.
Eligibility and criteria
IRB Number:
24-021971
Eligible age range:
Clinical trial phase:
N/A
Official title:
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.